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Abstract
Background: Tetracycline regulated ectopic gene expression is a widely used tool to study gene function. However, the
tetracycline regulator (tetR) itself has been reported to cause certain phenotypic changes in mammalian cells. We, therefore,
asked whether human myeloid U937 cells expressing the tetR in an autoregulated manner would exhibit alterations in gene
expression upon removal of tetracycline.
Methodology/Principal Findings: Microarray analyses revealed that 172 and 774 unique genes were significantly
differentially expressed by at least 2- or 1.5-fold, respectively, when tetR expressing U937 cells were maintained in media
with or without the antibiotic.
Conclusions/Significance: These alterations in gene expression are likely to contribute to the phenotypic consequences of
tetR expression. In addition, they need to be taken into consideration when using the tetR system for the identification of
target genes of transcription factors or other genes of interest.
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Introduction
Inducible ectopic expression is a widely used tool to study gene
function. Its advantages compared to constitutive approaches are
that early consequences of the presence of the investigated gene
product can be studied, and that it facilitates the analysis also of
growth inhibitory or cytotoxic gene products. Initial methods for
inducible gene expression were based on mammalian promoters
that could be activated, e.g., by metal ions. In the early 1990s, the
adaptation of the bacterial tetracycline repressor/operator system
for use in mammlian cells provided, for the first time, the
possibility to regulate the expression of exogenous genes through a
small molecule ligand that per se was expected not to affect the
physiology of mammalian cells due to their lack of endogenous
receptors for it [1]. In fact, mammalian cells need to be made
responsive to tetracycline by introduction of one of several
modified versions of the bacterial tetracycline regulator (tetR).
The transcriptional activity of some of these derivatives is
activated, and that of others repressed, by tetracycline or related
compounds [1,2]. In either case, the expression of genes cloned
downstream of a promoter containing several copies of the
bacterial tetracycline operator (tetO) can be regulated by removal
or addition of tetracycline or tetracycline derivatives from/to the
culture media. In further improvements of the system, tetR was
placed under the control of tetO elements to create an
autoregulatory loop, thus avoiding problems caused by toxicity
of constitutive tetR expression and reducing background levels of
the gene of interest in the repressed state [3,4].
Tetracycline regulated gene expression has also been used to
study the function of oncogenes involved in myeloid leukemia. A
popular model for this purpose is the human cell line U937, which
is able to differentiate into the monocytic lineage if stimulated with
appropriate agents [5–16]. In the course of such studies, we and
others have observed that control cells expressing only a tetR
derivative, or containing a tetR derivative plus the tetO vector
without a gene of interest, exhibited certain biological responses,
e.g. reduced proliferation or differentiation in the absence of
exogenous stimuli, to changes in the concentration of tetracycline
[5,6,10,12,15].
Many leukemogenic oncogenes are transcription factors that
are either aberrantly expressed or functionally altered as a
consequence of chromosome rearrangements. U937 derivatives
expressing such oncogenes in a tetracycline regulable manner
have also been used in several microarray studies aimed at the
identification of their downstream target genes [8,14,16]. Since,
however, tetracycline removal also modifies the cellular
behaviour of control U937 cells containing only the tetR but
no gene of interest, we set out to ask whether these phenotypic
alterations would be related to transcriptional changes. Indeed,
microarray analyses revealed that several hundred genes were
deregulated in tetR expressing U937 cells upon removal of
tetracycline.
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Results
Microarray analysis of U937 cells containing an
autoregulated tetR
The cell line U937T_pUHD10S contains a plasmid coding for
an autoregulated tetracycline repressor as well as the empty
pUHD10S vector, which drives tet-regulated expression of its
cDNA inserts. It was generated as a control for cell lines expressing
a gene of interest from pUHD10S. Three replicate cultures of
U937T_pUHD10S cells were transferred to media with or without
tetracycline. 48 h later RNA was extracted and used for
hybridization of Affymetrix U133 Plus 2.0 arrays. For statistical
evaluation, different levels of stringency were applied so as to
reflect stringency levels commonly found in the literature
[8,14,16]. 1191 probe sets (774 unique genes) were deregulated
at least 1.5-fold at p,0.05 upon removal of tetracycline from
U937T_pUHD10S cells (Tables 1 and S1A). If the threshold for
differential expression was increased to twofold and only genes
with a false discovery rate (FDR) ,10% after multiple hypothesis
testing were considered, 90 probe sets (99 unique genes) resulted as
deregulated (Tables 1 and S1B).
Confirmation of the regulation of selected genes by real
time quantitative (RTQ-) RT-PCR
Of the genes deregulated in response to tetracycline withdrawal,
CD36 (NM_000072; coding for the thrombospondin receptor) and
ITGAL (NM_002209; coding for alpha L integrin) were selected
for confirmation by RTQ-RT-PCR. Both genes form part of
several gene ontology categories that were significantly enriched
among genes induced by tetracycline removal (see below). RTQ-
RT-PCR indeed corroborated the upregulation of these genes
48 h after removal of tetracycline from the culture media of
U937T_pUHD10S cells. Both genes were also induced upon
withdrawal of tetracycline from U937T cells, which contain the
tetR, but not pUHD10S (Fig. 1A,B). A similar, albeit smaller and
less reproducible, effect was already present 24 h after transfer of
the cells to tetracycline free media (data not shown). To ask
whether the changes in the expression of these genes were related
to the induction of the autoregulated tetR, or represented an
endogenous response of mammalian cells to altered tetracycline
concentrations, native (i.e., untransfected) U937 cells were
cultured in the presence of tetracycline for one week. Then they
were washed and transferred to media with or without tetracycline
in the same manner as U937T_pUHD10S cells. Neither CD36 nor
ITGAL was induced upon transfer of native U937 cells to
tetracycline free media (Fig. 1C,D).
Gene ontology analysis
Gene ontology (GO) analysis revealed the terms "hemopoiesis",
"myeloid cell differentiation", "leukocyte activation", "phagocyto-
sis", "response to stress", "defense response", "immune system
process", "inflammatory response", "innate immune response",
"cell activation", "signal transduction", "chemotaxis", as well as
several others, to be significantly enriched among the genes
upregulated at least 1.5-fold at an FDR ,10% in response to
tetracycline withdrawal (Fig. 2, Table S2).
Discussion
Because we and others have found that tetR expressing cells
show phenotypic changes in response to altered concentrations of
antibiotic even if they do not contain a tetracycline regulated gene
of interest [5,6,10,12,15], we asked whether these changes may
correspond to altered gene expression patterns. Indeed, using
microarray analysis we found that the levels of several hundred
mRNAs were altered significantly after transfer of U937T_
pUHD10S cells to tetracycline free media. The mechanism
through which tetR affects gene expression is unclear and may
or may not involve direct interactions with DNA. Irrespectively, it
is plausible that the alterations in gene expression patterns in tetR
expressing U937 cells contribute to the phenotypic changes
observed in these cells after tetracycline withdrawal. Moreover,
even though tetR certainly does not play a physiological role in
human myeloid cells like U937, several of the gene ontology terms
enriched among the genes induced upon tetracycline removal
correspond to biological responses that might be expected as a
consequence of the experimental expression of a physiologically or
pathologically relevant gene. Similarly, altered gene expression
patterns may well contribute to recently reported phenotypic
consequences of tetR expression in transgenic mice, which were
observed even in the absence of any exogenous gene of interest
regulated by it [17].
Our results also have practical implications for studies aimed at
the identification of target genes of transcription factors or other
genes of interest. Because of the still considerable cost of
transcriptome analyses, some authors restrict their experiments
to the comparison of gene of interest-containing cells maintained
in the presence or absence of tetracycline. Factors of 1.5- or 2-fold
are often defined as thresholds for differential gene expression, and
rigorous statistical analyses including corrections for multiple
hypothesis testing are frequently not applied [8,14,16] (and
according to our experience would in fact prevent further
consideration of genes whose differential expression can be
confirmed by RTQ-RT-PCR). However, even after multiple
Table 1. Numbers of unique genes and probe sets deregulated in U937T_pUHD10S cells upon removal of tetracycline.
FC$1.5 p,0.05 FC$2 p,0.05 FC$1.5 FDR,10% FC$2 FDR,10%
unique genes upregulated 465 150 115 87
downregulated 309 22 46 12
total 774 172 161 99
probe sets upregulated 729 188 122 82
downregulated 462 31 40 8
total 1191 219 162 90
FC, fold change; FDR, false discovery rate according to Benjamini and Hochberg [20]. Because fewer hypotheses were tested when only unique genes rather than all
probe sets were considered, more unique genes than probe sets may pass the multiple hypothesis test in some cases.
doi:10.1371/journal.pone.0013013.t001
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hypothesis testing, 99 unique genes were deregulated more than
twofold in U937T_pUHD10S cells transferred to tetracycline free
media. While this number may appear small at first sight, it is large
enough to significantly confound the results of target gene
analyses, especially if the investigated gene of interest has few
true biological targets. Furthermore, the 774 genes that are
deregulated $1.5-fold at p,0.05 may also lead to erroneous
conclusions, and may do so even in analyses in which higher
stringency levels are applied: a gene that would be regulated
slightly less than twofold in control cells and slightly above this
threshold in gene of interest expressing cells may still not be a
relevant biological target of the investigated gene. Therefore, our
findings need to be taken into consideration when performing gene
expression experiments using the tetR system.
Materials and Methods
Cell lines and cell culture
Human U937 histiocytic lymphoma cells were cultured in a
humidified incubator at 37uC and 5% CO2 in RPMI 1640
medium (Invitrogen) containing 10% FBS (Invitrogen). To study
the effects of tetracycline removal, 1 mg/ml tetracycline (Sigma)
was added to the culture media for one week, and cells were then
processed as described below.
U937T cells have been derived from U937 cells by stable
transfection with a construct driving tetracycline-regulable expres-
sion of the tetVP16 fusion protein [5]. They were cultured in a
humidified incubator at 37uC and 5% CO2 in RPMI 1640
medium containing 10% FBS, 0.5 mg/ml puromycin (Sigma), and
1 mg/ml tetracycline. To obtain U937T_pUHD10S cells, U937T
cells were electroporated (0.17 kV, 950 mF) with the vector
pUHD10S, which contains seven copies of the tetracycline
operator, thus facilitating tetracycline regulable expression of its
cDNA inserts [18]. Transfectants were selected, cloned, and
propagated in RPMI 1640 medium supplemented with 10% FBS,
0.5 mg/ml puromycin, 1 mg/ml tetracycline, and 500 mg/ml
hygromycin (PAA). To remove tetracycline from the culture
media, exponentially growing cells were washed 3 times with
phosphate-buffered saline (PBS) and resuspended in growth media
without tetracycline. Control cultures were washed in the same
manner but resuspended in media with tetracycline.
Microarray analyses
RNA for microarray analyses was extracted from three
independent replicate cultures of U937T_pUHD10S cells using
the RNeasy Plus mini kit (Qiagen) according to the manufacturer’s
instructions. Quality control of the isolated RNA samples,
labelling, and hybridization to U133 Plus 2.0 arrays (Affymetrix)
were performed at the Center of Excellence for Fluorescent
Bioanalytics (KFB) in Regensburg, Germany, which is an
Affymetrix Service Provider and Core Facility. Sample prepara-
tion was carried out in accordance with the Affymetrix GeneChip
Expression Analysis Technical Manual (one replicate) or the
Affymetrix GeneChip IVT Express Kit Technical Manual (two
Figure 1. RTQ-RT-PCR confirms the induction of CD36 and ITGAL upon tetracycline withdrawal from U937 cell derivatives expressing
the tetR. A,B) U937T_pUHD10S cells and their parental cell line U937T, which contains the tetR but not the pUHD10S vector, were transferred to
media with (black columns) or without (white columns) tetracycline (tet). After 48 h, RNA was extracted and subjected to RTQ-RT-PCR. The expression
of CD36 (A) and ITGAL (B) relative to the housekeeping gene cyclophilinD was calculated using the DDCT method [19]. C,D) CD36 (C) and ITGAL (D)
expression in native U937 cells transferred to media with or without tetracycline after being cultured in the presence of the antibiotic for one week.
doi:10.1371/journal.pone.0013013.g001
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Figure 2. ClueGO analysis [22] of genes upregulated $1.5-fold at an FDR ,10% in U937T_pUHD10S cells upon tetracycline
withdrawal. Nodes (circles) represent gene ontology terms. Connections between two nodes (edges) indicate that two gene ontology terms share
genes from the considered dataset (agreement measure kappa .0.3). The calculated kappa score is also used for defining functional groups, which
are indicated by the same color. The most prominent gene ontology term for each group is highlighted.
doi:10.1371/journal.pone.0013013.g002
TetR Alters Transcription
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replicates). Briefly, total RNA was reverse transcribed into double
stranded cDNA, from which Biotin labeled cRNA was generated
using the One-Cycle Target Labeling Kit (Affymetrix) or the 39
IVT Express Labeling Kit (Affymetrix). The length of the cRNA
products was assessed using an Agilent 2100 bioanalyzer (Agilent
Technologies). Following fragmentation, cRNA products (15 mg)
were hybridized to the array for 16 h at 45uC in a rotating
chamber. Hybridized arrays were washed and stained in an
Affymetrix Washing Station FS450 using Streptavidin-Phycoery-
thrin conjugate (Life Technologies) together with biotinylated anti-
streptavidin antibody (Vector Laboratories), or, for the IVT
protocol, preformulated Hyb, Wash, and Stain (HWS) compo-
nents (Affymetrix). Fluorescent signals were measured with an
Affymetrix GeneChip Scanner 3000. Primary data analysis was
carried out using the Affymetrix MAS5 algorithm.
Real time quantitative reverse transcriptase polymerase
chain reaction (RTQ-RT-PCR)
Total RNA for RTQ-RT-PCR was extracted using Trizol
(Invitrogen) and reverse transcribed using random hexamer
primers (Invitrogen) and M-MLV reverse transcriptase (Invitro-
gen) according to the manufacturer’s instructions. RTQ-RT-PCR
was carried out in an ABI Prism 7700 Sequence Detection System
(Applied Biosystems) using the Mesa Green qPCR Master Mix
Plus (Eurogentec) according to the manufacturers’ instructions.
RTQ-RT-PCR primers are shown in Table 2. All assays were
carried out in triplicate. Expression values for the genes of interest
relative to the housekeeping gene cyclophilinD and to a reference
value were determined using the DDCT method [19].
Data evaluation and in silico analyses
Only probe sets with present calls in all six samples were
considered for statistical analyses, which were performed on log2-
transformed intensity values using the R/Bioconductor package
limma employing a moderated t-test. Probe sets whose average
expression differed at least 1.5- or 2-fold at p,0.05 between cells
maintained in the presence or absence of tetracycline were
considered as differentially expressed. Where indicated, multiple
hypothesis testing according to the method of Benjamini and
Hochberg [20] was performed, and probe sets with a false
discovery rate (FDR) ,10% were considered significantly
deregulated. Differentially expressed unique genes were identified
in the same manner, except that probe sets with no gene
annotation or with gene names including the term ‘‘hypothetical’’
were omitted, and for probe sets sharing the same gene annotation
only the most informative ones (i.e., those with the highest
interquartile range) were kept. All analyses were performed using
the statistical software environment R 2.10.1.
Over-represented gene ontology (GO) terms for up- or down-
regulated genes were identified using DAVID [21] based on gene
symbols. Up-regulated genes were functionally grouped into gene
ontology networks using the Cytoscape plug-in ClueGO [22].
Supporting Information
Table S1 Genes deregulated at least 1.5-fold at p,0.05 (Table
S1A) or at an FDR ,10% (Table S1B) upon withdrawal of
tetracycline from U937T_pUHD10S cells. FC, fold change; FDR,
false discovery rate.
Found at: doi:10.1371/journal.pone.0013013.s001 (0.19 MB
XLS)
Table S2 Gene ontology terms significantly overrepresented
among genes deregulated $1.5-fold at an FDR ,10% upon
withdrawal of tetracycline from U937T_pUHD10S cells. Count,
number of genes upregulated or downregulated in respone to
tetracycline withdrawal that are assigned to the named GO term;
%, percentage of genes upregulated or downregulated in respone
to tetracycline withdrawal that are assigned to the named GO
term. FDR, false discovery rate.
Found at: doi:10.1371/journal.pone.0013013.s002 (0.04 MB
XLS)
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